It’s estimated that over 3.5 million patients are unable to receive appropriate healthcare due to a lack of reliable transportation. This is the sole cause for many appointment “no-shows,” which inevitably leads to more emergency room visits. This has negative implications for both patients and caregivers. Uber Health and Cerner Corporation (NASDAQ: CERN), a health technologies company, are working together to combat this issue (http://ibn.fm/zF5o0).

Under the agreement, health providers can order ride requests for patients from Uber Health. In doing so, the patient’s contact information will auto-populate from Cerner directly into an Uber ride request, streamlining the booking process and ensuring patients have timely and reliable transportation to and from their medical appointments. The integration of the Uber Health app with Cerner’s EHR will soon be available across the United States.

“Joining forces with Cerner marks a new chapter for Uber Health and our mission to provide accessible, efficient transportation for patients and caregivers,” Dan Trigub, Head of Uber Health stated in the press release. “Reliable transportation to and from appointments can help reduce operating costs, patient no-show rates and help improve patient outcomes. Our goal is to simplify the way healthcare providers can access transportation options — and our work together will accomplish just that.”

Uber Health, which launched in March of 2018, is already working with large customers like BayCare, a client of Cerner. It’s estimated that this Florida health system will have organized over 20,000 rides using the Uber Health platform by the end of 2019.

For more information, visit the company’s website at www.Cerner.com

• InsuraGuest’s proprietary InsurTech software delivers a specialized policy to guests at the time of check-in
• The company targets both the vacations rental and hotel industry in the U.S., Europe, and the U.K, with plans to enter Asia in 2020
• Vacation rental market is highly lucrative with 297.17 million total vacation rental users worldwide

Service-as-a-software (SaaS) company InsuraGuest Inc. has signed a contract with Cal-Vegas, Ltd.(R) to provide its insurance product and services to the Red Lion Inn & Suites(R) property in South Carolina, according to a company press release (http://ibn.fm/IcYdw). Under the agreement, the Red Lion Inn & Suites will integrate InsuraGuest’s proprietary InsurTech software to offer its specialized insurance coverage to its guests at the time of check-in. InsuraGuest’s API will integrate with the hotel’s property management system.

The InsurTech software platform delivers a specialized guest protection policy, acting as the first line of defense against accidents and losses for both the guest and the hotel or vacation rental property. According to the contract signed with Cal-Vegas, the Red Lion Inn & Suites will purchase InsuraGuest coverage and supply it to all guests and room occupants on check-in.

The specialized policy covers accidental medical, accidental death and dismemberment, and theft of personal property while on property. The coverage is sold to the property and is automatically extended to the guest.

InsuraGuest created this insurance product for vacation rentals and hotel properties to fill an existing gap in traditional insurance. In most cases, insurance fails to adequately cover the full scope of risks that travelers and hotel or property owners face. InsuraGuest’s product aims to include different kinds of losses or accidents happening at vacation properties that are not the fault of the property directly, leaving guests with no claim to coverage.

The agreement with Cal-Vegas further strengthens InsuraGuest’s position on the U.S. market, where it operates coast-to-coast. The company is working on expanding the scope of its InsurTech platform and insurance products to cover European Union member states and the United Kingdom, with plans in motion to launch on the Asian market by mid-2020. The European and Asian hotel markets are both more significant than the U.S. market, holding a combined 5.4 billion hotel nights stayed in 2018, compared to 1.1 billion stayed nights in the United States.

While the U.S. hotel industry’s annual revenues grow consistently, reaching $218 billion in 2018, the vacation rental properties market is expanding considerably faster and is expected to topple the hotel industry by 2020 (http://ibn.fm/iQpFv). Statistics indicate that the vacation rental industry’s projected revenue in 2019 is $57.669 billion, with a market growth rate of 6.9 percent. There are 297.17 million total vacation rental users worldwide. Europe is leading this segment as well, accounting for 60 percent of all vacation rental properties on the market. The U.S. accounts for 20 percent, and the rest of the world accounts for the remaining 20 percent.

The fast-growing vacation rental property market is a lucrative opportunity for InsuraGuest, providing ample potential for expansion of operations and distribution of its insurance products and services. Expansion to the massive European hospitality market will further increase the company’s opportunities for growth.

For more information, visit the company’s website at www.InsuraGuest.com

NOTE TO INVESTORS: The latest news and updates relating to InsuraGuest are available in the company’s newsroom at http://ibn.fm/InsuraGuest

• Predictive Oncology is at forefront of growing trend of precision medicine
• The company applies smart tumor profiling, AI platform to extensive genomic and biomarker patient data sets
• POAI has large amounts of historical, standardized patient data from clinical testing that can be leveraged immediately

The moment has come for Predictive Oncology Inc. (NASDAQ: POAI). A knowledge-driven, precision-medicine company, POAI focuses on applying data and artificial intelligence to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to predict clinical outcomes and, most importantly, improve clinical outcomes for cancer patients of today and tomorrow.

While precision medicine, sometimes referred to as personalized medicine, is a relatively new term, the idea has been around for years (http://ibn.fm/KlNJH). Defined by the U.S. National Library of Medicine as “an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person,” the approach is gaining momentum as data sets especially in genomics have grown rapidly. Applying AI approaches to these large data sets offers the ability to more deeply analyze these data much faster and with more accurate results than previously.

Predictive Oncology is at the forefront of this growing trend that examines multiple factors about the patient from genomics, tumor profiles, nutrition, environmental factors, lifestyle and habits to determine a plan of action for treatment. In a recent overview (http://ibn.fm/pYVQI), POAI notes that for years, big pharma has invested tremendous resources — both financial and human — in genomics in order to understand a patient’s genome and hopefully provide more targeted treatments. However, despite the significant amount of time and money devoted to the research, success rates for such targeted therapies remain low, and adoption in clinical practice is lukewarm. It has become increasingly clear that genomics alone is not enough.

Experts are beginning to see a compelling need for a multi-omic approach, or a method that combines a variety of data sets including genome, transcriptome, epigenome, proteome, response-ome and microbiome. However, while this approach may provide a higher chance of successful treatment, accessing the data is proving to be challenging. Few comprehensive, multi-omic data sets exist, and initiating new data-collection projects are both time consuming and costly.

Enter Predictive Oncology. Competitors in the cancer field must wait at least five years to determine patient survival rates for specific treatments before they can show value in the data they have gathered. POAI, on the other hand, has vast amounts of historical data that it has been compiling for years, time-tested and proven data that can be leveraged today.

The company’s data includes two unique assets:

• A clinically validated, patient-derived (PDx), tumor-profiling platform that can generate drug-response profiles and other multi-omic data
• Data on the drug-response profiles of more than 150,000 tumors across 137 cancer types, validated by using the PDx platform in more than a decade of clinical testing.

In addition, the company continues to generate more data every day and has the ability to mine its existing assets to identify even more outcome data.

Predictive Oncology, which began as a joint venture between Skyline Medical and Helomics, is ideally positioned to harness the power of artificial intelligence and work with the pharmaceutical, diagnostic, and biotech industries to develop AI-driven predictive models of tumor drug response to impact patient outcomes.

For more information, visit the company’s website at www.Predictive-Oncology.com

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

• Growing awareness by public about how big companies track, sell personal data
• Owning, monetizing personal data possible through BIGtoken app
• Working to educate consumers on how to protect, own use of personal data

People are starting to understand how vulnerable their data is and how big companies such as Facebook, Twitter, Snapchat and other social-media platforms track and sell that data. Every individual creates data by what they search, view, read, listen to, purchase and like. That data is collected and sold, generating billions in revenue each year. SRAX Inc. (NASDAQ: SRAX), through its BIGtoken platform, is placing power of that data back into an individual’s hands. Through SRAX, consumers can now own and monetize their personal data.

In spring 2018, the European Union’s General Data Protection Regulation (GDPR) set guidelines that caused online companies worldwide with audiences in the EU to scramble for compliancy. While the United States doesn’t currently have the same restrictions, things are beginning to change. The California Consumer Privacy Act (CCPA) will go into effect Jan. 1, 2020. This new law will give consumers the ability to forbid a company from sharing their information and request that their information be deleted. Just as the GDPR had a worldwide ripple effect, the CCPA will affect any state that does business in California (http://ibn.fm/adXVl).

SRAX is a step ahead of privacy acts that will impact California and, potentially, the entire country. The company created BIGtoken as a way to place the power of data mining into an individual’s hands—and the company isn’t just doing it in one state but worldwide.

After being operational for a year, SRAX decided to poll its BIGtoken community regarding its data-privacy awareness. The survey yielded valuable insights into the way consumers view their online presence. For SRAX, one promising result of the survey showed that 62 percent of its users would allow more advertisements if they were being paid for the data that delivered the ad. Of concern for the company is its finding that the majority of consumers are concerned about browser privacy but aren’t as aware of how social-media apps have access to their data. Survey results indicated that many social-media users aren’t taking the basic steps necessary to protect themselves – and these stats come from a polled group that had opted into data privacy. Survey results clearly indicate much can still be done when it comes to educating and equipping consumers to take ownership of what is rightfully theirs.

SRAX has risen to the challenge with its BIGtoken Insight on Consumer Data Privacy (http://ibn.fm/njats). The SRAX platform provides agencies, businesses and individuals with the ability to grow brand awareness and loyalty. It places the brand’s information in the hands of individuals who are more likely to turn into a loyal customer rather than those who are targeted through data mining. Through SRAX, consumers have willingly opted into the targeted messages expressing an interest in the product. Because consumers are in charge of their own personal data and the brand’s use of that data, it creates transparency and trust between the two. Rather than receiving a request to delete data and potentially leaving on negative terms, brands are able to engage with pre-approval. A personalized shopper ad is experienced, foot traffic and purchases are increased, and the brand’s ROIs are increased.

BIGtoken works to provide quality information to the agencies, businesses and individual brands that will foster a long-term relationship between them and consumers. SRAX sells access to the data in the form of anonymized segments. This access can be removed at any time.

BIGtoken also works to educate consumers, letting them know what happens behind the scenes, how their data is accessed, and how much it is worth. Users worldwide can sign in to the BIGtoken app at any time to see how their data is being used and how much they have earned for that information. Surveys, check-ins and purchases all go toward earning rewards. The consumer can be paid with a deposit to PayPal or a gift card, or they can even donate their earnings to a charity of their choice. Sixteen million users worldwide have already opted into BIGtoken’s data-management solution, proving that there is a growing interest among consumers to be compensated by marketers for the use of personal data.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

The liberalization of cannabis has released a fast-growing, multibillion-dollar industry to cultivate, market and distribute product — and a whole lot more. Support services and systems are providing significant opportunities in logistics, technology, product development, branding, research and development, and regulatory compliance. Together, these opportunities create a value chain, unparalleled in recent times. Australis Capital Inc. (OTCQX: AUSAF) intends to explore those opportunities.

Australis Capital is focused on building the infrastructure required to meet the demands of the growing U.S. cannabis market including acquiring and building transformative companies to advance the cannabis industry. AUSAF is synthetizing decades of expertise, strategic alignments and capital investment to identify, acquire and partner with companies to meet the growing market demand. The company’s mission is to promote the healing, wellness and benefits of medicinal and recreational cannabis through high-quality products, experiences, innovations and accessibility.

Australis Capital is supported in that mission by a strong mentor and former parent company, Aurora Cannabis, the second-largest cannabis company in the world by market capitalization. Australis Capital (http://ibn.fm/47evN) is Aurora’s “backdoor strategy for entering the U.S. market.” Aurora cannot maintain its listings on the New York Stock Exchange (NYSE) and the Toronto Stock Exchange (TSX) if it has U.S. cannabis operations. Hence, the spin-off of Australis Capital. However, the much-smaller Canadian Securities Exchange (CSE) has no prohibitions against member companies doing business in the U.S. marijuana market.

Focused on furthering accessibility, well-being, health and the best possible experience from medicinal and recreational cannabis, Australis Capital operates the following eight brands and entities, five of which are fully owned.

Green Therapeutics (fully owned)

Green Therapeutics (GT) was founded in 2014 with the aim of providing safe, consistent, effective cannabis wellness products. The company has developed three prominent cannabis brands. Its Tsunami(TM) brand, a recreational line of products, is the top brand for live resin extracts in Nevada, while its Provisions(TM) line is well-known for premium distillate cartridges and cutting-edge sublingual sprays. Finally, the GT Flowers line provides consumers with selections from more than 150 different strains ranging from classics to the newest crosses, including many exclusive cuts.

Mr. Natural (fully owned)

Mr. Natural Inc. is the culmination of Bob “Natural” Luciano’s more than 50 years of cannabis expertise. A Vietnam veteran, Luciano first experimented with cannabis to treat post-traumatic stress disorder (PTSD). Australis Capital now offers a classic medical and recreational cannabis brand, internationally known for its quality, strong-THC products, which have won recognition for long-lasting duration, intense terpene profiles and organic flavors. Mr. Natural strains have won numerous awards, including the First High Times Medical Cannabis Cup and the 2009 L.A. Jemm Harvest Cup. All products used in the cultivation of Mr. Natural’s cannabis are certified organic.

Cocoon Rewards (fully owned)

Cocoon Rewards is a mobile platform that can be used to access U.S. cannabis dispensaries. Developed by Rthm Technologies Inc., the platform was originally a top health app available in 26 countries. Rthm holds several brand-associated trademarks and has developed the world’s first mobile-genetics and circadian-rhythm mapping platform for both iOS and Android devices.

Cocoon Technology (fully owned)

Cocoon Technology’s omni-commerce solution connects customers with dispensaries through state-of-the-art, self-service kiosks; integrated mobile applications; and tablets. The solution offers a cloud-based, self-service fulfillment platform called Cocoon Technology to dispense marijuana products. The Cocoon self-service kiosk is designed to sit inside a brick-and-mortar retail store, much like a vending machine.

AUSA Elements (fully owned)

AUSA Elements is an organic cultivation and production facility currently under construction, which will consist of the following:

• up to 219,000 square feet devoted to organic, state-of-the-art cultivation, manufacturing, and production
• up to 44,000 square feet for a CBD hemp house for oil extraction, product development, manufacturing, research and product storage.

The facility will house the following brands: Mr. Natural, Tsunami, Provisions and G.T. Flower. In addition, the facility will have an estimated flower capacity of 42,000 pounds annually and will utilize the most up-to-date cultivation and cannabis extraction equipment along with using proprietary hydrocarbon and ethanol technologies, including Wagner Dimas pre-roll technology. Capacity of the facility is expected to exceed 6 million pre-rolls annually. The greenhouse will be built to the Aurora Cannabis standard using ALPS Greenhouse Design, material and technology. The project is expected to be completed by September 2020.

Folium Biosciences (partially owned)

Folium Biosciences specializes in the cultivation, extraction and manufacture of hemp-derived, bulk-CBD ingredients and finished products. The company is the largest North American, vertically integrated producer, manufacturer and distributor of hemp-derived phytocannabinoids. Its Colorado facility is the largest phytocannabinoid extraction and purification facility in the United States. Folium Biosciences employs a unique engineering process that enables the separation and removal of unwanted compounds while creating the maximum potency level of phytocannabinoids, terpenes, terpenoids and flavonoids. Wholesale CBD products sold by Folium include broad-spectrum hemp oil (with 0.0 percent THC), water-soluble CBD powder, water-soluble CBD liquid and Nano CBD. Folium’s emphasis on research, product development and clinical science, reflected in its state-of-the-art extraction processes and advanced formulations, has resulted in several pending patents.

Quality Green (partially owned)

Quality Green, founded in 2013, is an ACMPR-licensed producer based in Canfield, Ontario. The company owns and operates a 50,000-cGMP-square-foot greenhouse widely recognized for its optimized production efficiency, best practices and high standards. Expansion plans are currently underway. In Q1 2019, the company established Quality Green Deutschland GmbH in Germany, and in Q2 2019, Quality Green’s application for an HC Import license for new genetics was approved.

Body and Mind Inc. (partially owned)

Body and Mind Inc. (OTC: BMMJ) invests in medical and recreational cannabis cultivation, production and retail assets. Its wholly owned Nevada subsidiary was awarded one of the first medical-marijuana cultivation licenses and now holds a production license as well. BMMJ products include dried flower, edibles, topicals, extracts and GPEN Gio cartridges. BMMJ marijuana strains have won numerous awards including the Las Vegas Hempfest Cup 2016, High Times Top Ten, the NorCal Secret Cup and the Emerald Cup. The company continues to expand operations in Nevada and Ohio and is constantly reviewing additional accretive expansion opportunities. As of May 30, 2019, Australis owned 37.7 percent of BMMJ’s issued and outstanding shares.

For more information, visit the company’s website at www.AUSA-Corp.com

• Edible cannabis products are absorbed slowly
• Consumers of cannabis edibles often mistake the delayed effect for insufficiency, leading to overdosing
• DehydraTECH drug-delivery platform speeds up absorption, reducing overdose risk

Sometimes what is gained on the roundabouts is lost on the swings, to paraphrase an old saying. Cannabis liberalization has introduced an entirely new sector to the food and beverage industry – namely, cannabis edibles such as cookies, chocolates and candies. It’s a sector that appears poised for growth. But as mass consumption increases, a hidden problem is emerging (http://ibn.fm/E1DSr). Because bioabsorption rates via edibles are slower than those via smoking, oral ingestion is leading to unexpected challenges. Consumers mistake the slow onset of effect of traditional cannabis edibles for not enough cannabinoid, so they increase consumption which can lead to overdosing. However, a biotech solution from Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) appears to solve this problem. The company’s DehydraTECH(TM) drug-delivery platform greatly increases the rate at which drugs like cannabis are absorbed by the body. The technology could be used to avoid overdoses before they ever begin.

Consumers have certainly developed a taste for cannabis. A recent report projects the global cannabis-edibles market will reach over $11.6 billion by 2025, climbing at a CAGR of 25 percent, from $2.4 billion in 2018 (http://ibn.fm/Yc1rF). One reason for this rapid mass adoption is the promise that oral ingestion is safer. The reality is more complicated.

A March 2019 report in the ‘Annals of Internal Medicine’ (http://ibn.fm/W1uTf) states that edibles are being associated with “medical complications that we never knew were associated with marijuana.” Patients “who ingested the drug were more likely to suffer more severe effects, including psychiatric symptoms and heart problems,” with “18 percent of edible users suffering symptoms such as anxiety and psychosis compared with about 11 percent of cannabis smokers.”

There are three reasons why edible cannabis is very different than smoked. One is, as noted above, that edible delivery of drugs is always slower than pulmonary delivery. A second difference is that smoking has been associated with lung cancers and emphysema, whereas edibles have not. And the third difference is that traditional edibles – prior to Lexaria’s technology becoming available – deliver cannabinoids across the intestinal wall and into the liver, where it is transformed into a very different metabolite of the traditional Delta-9 that smokers are more familiar with.

The human liver metabolizes the Delta-9 and changes it to Delta-11-Hydroxy (11-OH-THC) which produces different, stronger psychoactive effects for most users. And the metabolization process takes time – usually 1 to 2 hours – which explains the long delays associated with old fashioned edibles.

Lexaria’s technology ingeniously bypasses first-pass liver metabolism, delivering more of the THC in the Delta-9 variant, the same as smoking. This is how Lexaria manages to deliver the drug more quickly and in a form more familiar to cannabis smokers.

Earlier this year, Lexaria commenced a series of animal studies that, among other things, sought to improve understanding of how edible forms of cannabinoids enter the bloodstream. The company compared its standard DehydraTECH formulation, which combines cannabinoids with long-chain fatty acids (LCFA) using its patented, dehydration-processing technique, to a concentration-matched formulation utilizing coconut oil, a medium-chain triglyceride (MCT) oil commonly used in the cannabis edibles industry. Test results showed the following (http://ibn.fm/xQYq2):

• The DehydraTECH formulation delivered measurable quantities of cannabidiol (CBD) into the blood in as little as 2 minutes.
• Lexaria’s technology delivered more CBD to the bloodstream in 15 minutes than conventional MCT oil-based control formulations achieved in 60 minutes.
• Lexaria’s DehydraTECH formulation delivers cannabinoids at industry-leading volumes and speed while effectively masking bitter flavor and aroma profiles.

Lexaria’s patented DehydraTECH LCFA formulation offers a more effective delivery mechanism than MCT oils, which are widely used by many firms making and selling cannabis edibles throughout North America. Although the studies tested only for CBD delivery, the company has every reason to believe that virtually identical results would have been achieved if THC had been the cannabinoid under examination.

Application of the technology extends beyond nicotine to non-psychoactive cannabinoids, vitamins and nonsteroidal anti-inflammatory drugs (NSAIDs), as well as nicotine. Lexaria licenses the technology to leading cannabis edibles companies across North America.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

• Bragg Gaming Group is a betting platform innovator that specializes in identifying online gaming opportunities with a focus on both B2B and B2C companies
• Bragg recently announced that it will partner with sports betting provider Kambi Group to serve the sportsbook and eventual online gaming needs of the Seneca Gaming Corp. in the Buffalo-Niagara tourism-heavy region of Western New York
• Bragg reported C$18 million in revenues during the first six months of 2019 and anticipates record revenue growth of over 25 percent during the third quarter

Budding betting platform innovator Bragg Gaming Group Inc. (TSX.V: BRAG) (OTCQX: BRGGF) has announced its first foray into the U.S. gaming market with a significant three-partner agreement that leverages Bragg’s world-class casino services and player account management (PAM) system for a planned sportsbook and online gaming operation in the tourism-heavy Niagara region of Western New York.

The agreement (http://ibn.fm/IMVuz), announced November 5, subject to regulatory approval, teams the gaming platform of Bragg subsidiary ORYX Gaming with the on-property sports wagering portfolio of global sports betting provider Kambi Group plc and the three Class III brick-and-mortar casinos operated by Seneca Gaming Corp. at Niagara Falls, Buffalo and Salamanca (Allegany Indian Reservation), New York.

According to the announcement, Seneca Resorts & Casinos, which recently became the exclusive casino partner of the Buffalo Bills, will now begin the roll-out of on-property sportsbooks, enabling all three casinos to offer sports betting before the end of the year.

Bragg and Kambi also expect to launch online and mobile sports wagering and casino gaming through the Seneca network once New York approves those products and grants the necessary regulatory clearance. Sportsbooks are a fledgling industry in New York, approved in 2013 and only just beginning to open this summer at upstate tribal and commercial facilities (http://ibn.fm/HwWNo). Statewide access through mobile operations remains elusive at the present, although a legislative bill currently in motion seeks to change the dynamic to prevent New York resident sports gaming dollars from flowing out to New Jersey (http://ibn.fm/Qw90d).

“The agreement with Bragg and Kambi is a huge win for our customers,” Seneca Gaming Corp. President and CEO Holly Gagnon stated in a news release. “Providing access to sports betting has been something that our customers have long looked forward to, and Bragg’s world-class casino and player account management services, together with Kambi’s market-leading sports wagering products, will create a fantastic customer experience that we can’t wait to offer.”

Bragg is a next-generation gaming group with cutting-edge technology, leading brands and global management expertise. Bragg’s ORYX Gaming subsidiary was acquired last year, providing the company with an innovative B2B i-gaming technology platform and casino content aggregator licensed internationally to provide turnkey solutions in Malta, Schleswig Holstein, Spain, Romania, Colombia, Croatia, Serbia, Gibraltar, UK and Slovenia.

The company acquired GIVEMESPORT, a next-generation sports media company with the largest single sports publisher Facebook page in the world, in 2017. GIVEMESPORT has over 26 million fans and generates over 3.6 billion impressions, reaching over 138 million unique users per month on Facebook alone.

For the six months ended June 30, Bragg reported revenues of C$18 million, with a gross profit (excluding depreciation and amortization) of $8.3 million (http://ibn.fm/3zFai). The company announced last month that it is anticipating record revenue growth during the third quarter, which it will discuss during the company’s third quarter 2019 conference call on Nov. 12 (http://ibn.fm/3gavX).

“We expect to achieve Q3 2019 revenue growth of over 25 per cent against the same period last year and sequential revenue growth of over 10 per cent,” Bragg CEO Dominic Mansour stated in a news release. “Year-to-date, revenue is up over 35 per cent from the first nine months of 2018. In addition, September was our best month since Bragg’s inception with average daily volume through our aggregator platform hitting record numbers.”

For more information, visit the company’s website at www.Bragg.games

• Green Hygienics completes acquisition of the 824-acre Potrero Ranch property which includes 400,000 square feet of greenhouse space near San Diego, California, allowing for multiple industrial hemp harvests
• Green Hygienics farming methodology addresses the challenge of scalability. The Company’s cultivation capability far exceeds that of the average-size hemp farm in North America, which stalls at around nine acres
• The company’s pending acquisition, a head office and warehouse property, will serve as its head office for corporate administration and potentially manufacturing; supporting cultivation and processing will take place at the Potrero Ranch strategically located just 45 minutes away

Green Hygienics Holdings Inc. (OTCQB: GRYN), a full-scope, premium hemp cultivation and branding enterprise focused on the cultivation and processing of industrial hemp for the purpose of extracting cannabidiol (CBD), is well-positioned to take advantage of this booming sector of the economy. Fresh off a news release detailing the company’s acquisition of the 824-acre Potrero Ranch Property (http://ibn.fm/xvjDO), GRYN announced it has opened escrow for the acquisition of its head office and warehouse building in the prestigious Poway Business Park, both located near San Diego, California.

Green Hygienics’ holds a major competitive advantage over industry peers in cultivating premium products through its scientific methodology combined with sustainable farm practices. Producing higher yields on a consistent basis, while remaining compliant through diligent testing, is the hallmark of Green Hygienics’ business model.

Hemp cultivation dramatically increased once federal restrictions on hemp farming were lifted through passage of the 2018 Farm Bill, according to advocacy group Vote Hemp in its 2019 U.S. Hemp License Report (http://ibn.fm/d98EB). Finding success with this versatile crop, however, has been elusive for some farmers, the report states, with up to a 60 percent failure rate of harvests. Currently, the average-size hemp farm in North America is nine acres, which means every inch of that land must be productive in order for farmers to reap a profit.

With 25 years of experience in agricultural science and innovation, Green Hygienics has solved the challenge of scalability through its farming methodology. In today’s market, inefficient companies and those that produce an inferior product will become vulnerable or disappear, adding considerable value to companies like Green Hygienics that efficiently innovate and operate. Securing the 824-acre Potrero Ranch property, which includes abundant water and over 400,000 square feet of outbuildings, will allow GRYN to achieve multiple harvests of high-quality industrial hemp and accelerate its market position.

“We have been working at the property under a lease agreement for the last three months purchasing equipment and preparing to begin cultivation immediately,” Loudoun stated in a news release. “The combination of the greenhouse space and acreage will create the capability to produce significant revenues for Green Hygienics.”

By controlling its own supply chain, Green Hygienics can also leverage strategic advantages in the marketplace, such as the ability to deliver a “best in class” product on a consistent basis. The company strives to constantly develop innovations in industrial hemp for CBD cultivation and to create solutions that lower costs, deliver higher yields and address the challenges of large-scale production.

For more information, visit the company’s website at www.GreenHygienicsHoldings.com

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at  http://ibn.fm/GRYN

• New subsidiary inks contracts totaling millions for record 60-day performance
• Direct Solar adds alternative-energy financing solution to reach wider markets
• Company joins forces with country’s second-fastest real-estate brokerage

A diversified holding company, SinglePoint Inc.’s (OTCQB: SING) largest acquisition to date has definitely paid off. Acquired by SING in May, Direct Solar posted record sales in its first 60 days with the company, added a new division to reach untapped markets, and signed a partnership with one of the fastest-growing real-estate brokerages in the nation. Based on the subsidiary’s performance thus far, SinglePoint is forecasting record sales for this year, with even higher numbers projected for 2020.

During its first 30 days with SING, Direct Solar brought in $1.7 million in contracts and then repeated the performance during the next 30 days for a total of more than $3.4 million in signed contracts (http://ibn.fm/9AuCZ) in a two-month period. Those contracts have since moved into planning and installation phases, with the bulk of the revenue recognized upon contract completion, slated for third and fourth quarters in most cases. The company anticipates Direct Solar’s sales numbers to continue along the same trajectory, reaching a projected $5 million in contract sales by the end of 2019.

The subsidiary hit other milestones this year as well. Within weeks of joining SinglePoint, Direct Solar added an alternative-energy financing solution – Direct Solar Capital – in an effort to expand its reach and offer services to wider markets. Direct Solar originally only serviced resident contracts, but its addition of Direct Solar Capital allowed the company to serve medium commercial enterprises (http://ibn.fm/K7uC1). Businesses that have an alternative-energy project ready to go now have access to anywhere from $50,000 to $3 million in funding.

In addition, Direct Solar joined forces with My Home Group, the fastest-growing real estate brokers in Arizona and the second-fastest brokerage in the country. The new partnership allows My Home Group’s nationwide network of more than 2,300 agents to provide alternative-energy options for homeowners who want to reduce their reliance on the grid, lower their utility bills or utilize cleaner, alternative-fuel systems.

The success of Direct Solar is creating a solid financial base for SING as it continues to expand and seek out additional acquisitions. “The traction we have experienced so far has been amazing,” Direct Solar Founder Pablo Diaz said in a news release (http://ibn.fm/qeKue). “We are thrilled for the achievements we have accomplished and are looking forward to continually improving. We are now exploring ways to generate additional sales through innovative marketing strategies. I’m confident we will hit $15 million in 2020.”

SinglePoint acquires small to mid-sized businesses. The company’s focus is on new technologies. Investments in renewable energy, legal ancillary cannabis, and hemp are only a few examples of the multiple industries and verticals included in SinglePoint’s diversified portfolio. By investing in undervalued subsidiaries, the company has grown from a full-service mobile technology provider to a recognizable brand with multiple revenue streams.

For more information, visit the company’s website at www.SinglePoint.com

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

• REITs integral in technological advancements, should be key to success of 5G rollout
• Spectrum looks to assist in advancement by providing comprehensives expertise, services through subsidiaries
• 5G network systems expected to deliver broad range of benefits

Infrastructure real-estate investment trusts (REITs) often play key roles in a community’s technological progress and advancement. As 5G technology rolls out, these organizations are looking to continue their invaluable involvement and support, which benefits companies such as Spectrum Global Solutions Inc. (OTCQB: SGSI) that are involved in 5G development. Spectrum is a leading provider of comprehensive outsourced services and solutions for the deployment and maintenance of next-generation and legacy wireless and wireline telecommunication networks and infrastructure.

“Infrastructure REITs play an integral role in shaping our communities by providing the backbone for new technology to take hold and connect us in ways barely imagined just a few years ago,” reports a recent NAREIT article (http://ibn.fm/BO5aH). “Like the rest of the REIT industry, infrastructure REITs encompass a range of specialties, but the primary purpose of those supporting the digital economy lie in cell towers, small cell technology, fiber connectivity and data center platforms. By developing essential infrastructure, these REITs are helping to provide benefits as diverse as improved digital literacy in remote areas, access to telehealth and other online health services, and remote energy usage monitoring — to highlight just a few examples.”

Spectrum will be an eager partner as infrastructure REITs work to build digitally connected communities. The company provides end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to service-provider (carrier) and corporate-enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. The company offers these vital services through the following subsidiaries:

• ADEX Corporation and ADEX Puerto Rico LLA, an international service organization that provides turnkey services and project staffing solutions exclusively to the telecommunications industry.
• AW Solutions Inc. and AW Solutions Puerto Rico, an organization that works directly with communication carriers, enterprise businesses, OEMs and professional-service companies to provide cost-effective, scalable and robust solutions in their technology deployments.
• TNS Inc., a communications contractor specializing in the design, installation and maintenance of structured cabling systems.
• Tropical Communications Inc., a state-licensed electrical and underground utility contractor whose expertise includes all types of communications wiring, low-voltage and underground-utility contracting, fiber-optic systems, splicing, testing and wireless capabilities.

Spectrum’s services range in scope from a single activity to multiyear, multiregion, large-scale turnkey development contracts with an impressive array of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

The arrival of 5G network systems is expected to immediately improve the performance of current wireless services by providing higher access speeds, lower latency (less delay in processing data messages) and more system capacity. In addition, a recent Accenture report projected 5G wireless technology will also provide significant economic and community benefits, including the anticipated creation of three million new jobs and a $500 billion boost to annual GDP (http://ibn.fm/2rSys). Spectrum looks forward to being an integral part of this next-generation technology boon.

For more information, visit the company’s website at www.SpectrumGlobalSolutions.com

NOTE TO INVESTORS: The latest news and updates relating to SGSI are available in the company’s newsroom at http://ibn.fm/SGSI